The extent and nature of CD8+ T cell activation is strongly influenced by the quality of T cell receptor (TCR)/peptide MHC interaction (signal 1) and the presence, type and strength of signaling through costimulatory receptors (signal 2); lack of appropriate costimulation has been shown to impact effective anti-tumor immune responses5. The gene discussed is CD8A; the disease is neoplasm.